Publisher
Springer International Publishing
Reference34 articles.
1. Beilmann, M., Boonen, H., Czich, A., Dear, G., Hewitt, P., Mow, T., Newham, P., Oinonen, T., Pognan, F., Roth, A., Valentin, J.-P., Van Goethem, F., Weaver, R., Birk, B., Boyer, S., Caloni, F., Chen, A., Corvi, R., Cronin, M., … Steger-Hartmann, T. (2019). Optimizing drug discovery by investigative toxicology: Current and future trends. ALTEX - Alternatives to Animal Experimentation, 36(2), 289–313. https://doi.org/10.14573/altex.1808181
2. Bogers, M., Zobel, A.-K., Afuah, A., Almirall, E., Brunswicker, S., Dahlander, L., Frederiksen, L., Gawer, A., Gruber, M., Haefliger, S., Hagedoorn, J., Hilgers, D., Laursen, K., Magnusson, M. G., Majchrzak, A., McCarthy, I. P., Moeslein, K. M., Nambisan, S., Piller, F. T., … Ter Wal, A. J. (2017). The open innovation research landscape: Established perspectives and emerging themes across different levels of analysis. Industry & Innovation, 24(1), 8–40.
3. Bogers, M., Chesbrough, H., & Moedas, C. (2018). Open innovation: Research, practices, and policies. California Management Review, 60(2), 133–144.
4. Chesbrough, H. W. (2003). Open innovation: The new imperative for creating and profiting from technology. Harvard Business School Press.
5. Chesbrough, H. W. (2006). Open business models. How to thrive in the new innovation landscape. Harvard Business School Press.